Literature DB >> 19332045

Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults.

K Douroudis1, E Prans, K Kisand, V Nemvalts, R Uibo.   

Abstract

BACKGROUND: Cytotoxic T lymphocyte antigen-4 (CTLA-4) molecule is an important regulator of T cell activation involved in the down-regulation of immune response. Polymorphisms within the CTLA-4 gene have been suggested to confer susceptibility to autoimmune endocrine disorders.
METHODS: In order to evaluate the impact of allelic variants of the CTLA-4 gene in latent autoimmune diabetes in adults (LADA), the CT60 A/G SNP and the CTBC217_1 C/T SNP were studied in a population of Estonian origin, including 61 LADA patients and 230 controls.
RESULTS: It was found that the CT60 GG genotype (p=0.004) and the CTBC217_1 TT genotype (p=0.007) were significant associated with LADA.
CONCLUSIONS: Our investigation revealed that not only type 1 diabetes but also LADA is associated with CTLA-4 gene polymorphisms. The role of CTLA-4 gene in the pathogenesis of LADA is open and needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332045     DOI: 10.1016/j.cca.2009.03.036

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.

Authors:  P Jin; B Xiang; G Huang; Z Zhou
Journal:  J Endocrinol Invest       Date:  2014-09-04       Impact factor: 4.256

2.  Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease.

Authors:  Dor Mohammad Kordi Tamandani; Mohammad Hashemi; Sara Shafiepour
Journal:  Indian J Hum Genet       Date:  2013-04

Review 3.  The soluble CTLA-4 receptor and its role in autoimmune diseases: an update.

Authors:  Daniele Saverino; Rita Simone; Marcello Bagnasco; Giampaola Pesce
Journal:  Auto Immun Highlights       Date:  2010-11-04

4.  Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.

Authors:  Yung-Luen Shih; Hsu-Feng Lu; Chiao-Wan Hsiao; Kuo-Ting Ho; Pei-Chi Chen; Chien-Ning Huang; Yuanmay Chang; Shang-Jyh Kao; Ming-Yuh Shiau; Yih-Hsin Chang
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

5.  The Relationship between insulin variable number of tandem repeats (INS-VNTR) -23 A/T and cytotoxic Tlymphocyte associated protein-4 (CTLA-4) +49 A/G polymorphisms with islet autoantibodies in persons with diabetes.

Authors:  Mohammad Khoshroo; Mohammad Ebrahim Khamseh; Ali Akbar Amir Zargar; Mojtaba Malek; Reza Falak; Mehdi Shekarabi
Journal:  Med J Islam Repub Iran       Date:  2017-12-12

6.  Cytotoxic T-lymphocyte antigen-4 +49A/G polymorphisms in Sudanese adults with type 1 diabetes and latent autoimmune diabetes.

Authors:  Shimos A Alshareef; Saeed M Omar; Hamdan Z Hamdan; Ishag Adam
Journal:  BMC Res Notes       Date:  2019-11-26

Review 7.  Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.

Authors:  Jingyi Hu; Rong Zhang; Hailan Zou; Lingxiang Xie; Zhiguang Zhou; Yang Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-21       Impact factor: 6.055

Review 8.  Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.

Authors:  Margaret A McBride; Tazeen K Patil; Julia K Bohannon; Antonio Hernandez; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.